America is in the middle of a GLP-1 gold rush. Millions are turning to drugs like Ozempic, Wegovy and tirzepatide for dramatic weight loss. But are doctors and weight-loss clinics doing it wrong?

These drugs can deliver impressive results, but there are important questions about dosing, muscle loss, side effects, nutrition and what happens when the weight comes off. Most importantly, is there a smarter way to use GLP-1s while protecting your long-term health?

My guest is Peter Gillooly, CEO of The Wellness Company, which itself offers tirzepatide. So this isn't an anti-GLP-1 conversation. It's about the right way versus the wrong way to use these powerful medications.

And TWC is taking a different approach with its tirzepatide program, emphasizing medical oversight, lower-dose treatment and a strategy designed around sustainable weight loss rather than simply chasing the biggest number on the scale. Peter explains what makes their approach different and why he believes it matters.

On Stinchfield, we separate the GLP-1 hype from reality and reveal what you need to know before beginning a weight-loss program.

Learn more at TWC.Health/Grant and use promo code GRANT for 10% off.